Pro-Dex Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
Pro-Dex wird ein Gewinn- und Umsatzwachstum von 18.2% bzw. 5.8% pro Jahr prognostiziert, während der Gewinn pro Aktie um 15.9% pro Jahr wachsen soll.
Wichtige Informationen
18.2%
Wachstumsrate der Gewinne
15.9%
EPS-Wachstumsrate
Medical Equipment Gewinnwachstum | 17.0% |
Wachstumsrate der Einnahmen | 5.8% |
Zukünftige Eigenkapitalrendite | n/a |
Analystenabdeckung | Low |
Zuletzt aktualisiert | 10 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
This Analyst Just Made A Massive Upgrade To Their Pro-Dex, Inc. (NASDAQ:PDEX) Earnings Forecasts
Nov 13Pro-Dex, Inc. (NASDAQ:PDEX) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected
Nov 05Pro-Dex, Inc.'s (NASDAQ:PDEX) P/E Is Still On The Mark Following 37% Share Price Bounce
Sep 10The Returns On Capital At Pro-Dex (NASDAQ:PDEX) Don't Inspire Confidence
Jul 18Investors Can Find Comfort In Pro-Dex's (NASDAQ:PDEX) Earnings Quality
Feb 16Here's Why Pro-Dex (NASDAQ:PDEX) Can Manage Its Debt Responsibly
Feb 14Pro-Dex, Inc.'s (NASDAQ:PDEX) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Jan 24Pro-Dex (NASDAQ:PDEX) Has A Pretty Healthy Balance Sheet
May 20Pro-Dex (NASDAQ:PDEX) Could Be Struggling To Allocate Capital
Oct 05Pro-Dex: Growth Trends In Earnings, Return On Investment Contracting
Sep 26When Should You Buy Pro-Dex, Inc. (NASDAQ:PDEX)?
Sep 20Pro-Dex GAAP EPS of $0.38, revenue of $12.61M
Aug 25Is Now The Time To Look At Buying Pro-Dex, Inc. (NASDAQ:PDEX)?
May 10Is Pro-Dex (NASDAQ:PDEX) Using Too Much Debt?
Apr 21Pro-Dex (NASDAQ:PDEX) Is Doing The Right Things To Multiply Its Share Price
Mar 14Is Pro-Dex, Inc. (NASDAQ:PDEX) Potentially Undervalued?
Feb 09We Think Pro-Dex (NASDAQ:PDEX) Is Taking Some Risk With Its Debt
Nov 17Is It Too Late To Consider Buying Pro-Dex, Inc. (NASDAQ:PDEX)?
Aug 29A History Of Strong Growth Rates: Pro-Dex On Sale
Aug 25The Return Trends At Pro-Dex (NASDAQ:PDEX) Look Promising
May 18What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?
Mar 29Is Weakness In Pro-Dex, Inc. (NASDAQ:PDEX) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Mar 15The Pro-Dex (NASDAQ:PDEX) Share Price Is Up 732% And Shareholders Are Delighted
Feb 26Independent Director William Farrell Just Sold A Bunch Of Shares In Pro-Dex, Inc. (NASDAQ:PDEX)
Feb 13We Like These Underlying Trends At Pro-Dex (NASDAQ:PDEX)
Feb 08Pro-Dex EPS misses by $0.27, misses on revenue
Feb 04Is Pro-Dex (NASDAQ:PDEX) A Risky Investment?
Jan 25What Is The Ownership Structure Like For Pro-Dex, Inc. (NASDAQ:PDEX)?
Jan 11How Much Are Pro-Dex, Inc. (NASDAQ:PDEX) Insiders Taking Off The Table?
Dec 28With EPS Growth And More, Pro-Dex (NASDAQ:PDEX) Is Interesting
Dec 14What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?
Nov 30Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
6/30/2026 | 63 | 7 | N/A | 3 | 1 |
6/30/2025 | 61 | 7 | N/A | 6 | 1 |
9/30/2024 | 57 | 5 | 6 | 8 | N/A |
6/30/2024 | 54 | 2 | 5 | 6 | N/A |
3/31/2024 | 49 | 2 | 5 | 6 | N/A |
12/31/2023 | 48 | 3 | 3 | 4 | N/A |
9/30/2023 | 47 | 5 | 2 | 3 | N/A |
6/30/2023 | 46 | 7 | 4 | 5 | N/A |
3/31/2023 | 48 | 8 | -2 | 0 | N/A |
12/31/2022 | 44 | 7 | -4 | -3 | N/A |
9/30/2022 | 43 | 5 | -2 | -1 | N/A |
6/30/2022 | 42 | 5 | -3 | -1 | N/A |
3/31/2022 | 39 | 3 | 3 | 5 | N/A |
12/31/2021 | 41 | 5 | -2 | 1 | N/A |
9/30/2021 | 39 | 6 | -8 | 2 | N/A |
6/30/2021 | 38 | 6 | -10 | -2 | N/A |
3/31/2021 | 40 | 8 | -8 | 0 | N/A |
12/31/2020 | 36 | 7 | -4 | 3 | N/A |
9/30/2020 | 36 | 6 | 3 | 3 | N/A |
6/30/2020 | 35 | 6 | 4 | 5 | N/A |
3/31/2020 | 31 | 4 | 2 | 3 | N/A |
12/31/2019 | 29 | 4 | 3 | 4 | N/A |
9/30/2019 | 27 | 4 | 3 | 4 | N/A |
6/30/2019 | 27 | 4 | 2 | 3 | N/A |
3/31/2019 | 26 | 3 | 3 | 4 | N/A |
12/31/2018 | 25 | 3 | 3 | 3 | N/A |
9/30/2018 | 24 | 2 | 1 | 3 | N/A |
6/30/2018 | 22 | 2 | N/A | 3 | N/A |
3/31/2018 | 22 | 2 | N/A | 3 | N/A |
12/31/2017 | 23 | 2 | N/A | 4 | N/A |
9/30/2017 | 22 | 5 | N/A | 4 | N/A |
6/30/2017 | 22 | 5 | N/A | 3 | N/A |
3/31/2017 | 21 | 4 | N/A | 3 | N/A |
12/31/2016 | 20 | 4 | N/A | 2 | N/A |
9/30/2016 | 20 | 2 | N/A | 1 | N/A |
6/30/2016 | 19 | 1 | N/A | 0 | N/A |
3/31/2016 | 18 | 1 | N/A | -1 | N/A |
12/31/2015 | 17 | 0 | N/A | -1 | N/A |
9/30/2015 | 15 | 0 | N/A | -2 | N/A |
6/30/2015 | 13 | 0 | N/A | -1 | N/A |
3/31/2015 | 13 | 0 | N/A | 0 | N/A |
12/31/2014 | 11 | -1 | N/A | 1 | N/A |
9/30/2014 | 11 | -1 | N/A | 1 | N/A |
6/30/2014 | 11 | -1 | N/A | 0 | N/A |
3/31/2014 | 10 | -1 | N/A | 0 | N/A |
12/31/2013 | 11 | -2 | N/A | -1 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: PDEXDas prognostizierte Gewinnwachstum (18.2% pro Jahr) liegt über der Sparquote (2.6%).
Ertrag vs. Markt: PDEXDie Erträge des Unternehmens (18.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (15.4% pro Jahr).
Hohe Wachstumserträge: PDEXDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: PDEXDie Einnahmen des Unternehmens (5.8% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (9% pro Jahr).
Hohe Wachstumseinnahmen: PDEXDie Einnahmen des Unternehmens (5.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von PDEX in 3 Jahren voraussichtlich hoch sein wird